@article{37e88458d29043b08fe13baa972703d5,
title = "Novel therapies to achieve the recommended low-density lipoprotein cholesterol concentration (LDL-C) targets for patients after coronary artery bypass grafting",
keywords = "PSCK9 inhibitor, atherosclerosis, bempedoic acid, coronary artery bypass grafting, coronary artery disease, ezetimibe, inclisiran, statin intolerance, statin-associated muscle symptoms",
author = "Deo, {Salil V.} and Sadeer Al-Kindi and Virani, {Salim S.} and Stephen Fremes",
note = "Funding Information: S.V. reported research support from the Department of Veterans Affairs , National Institutes of Health , and the Tahir and Jooma Family . Funding Information: S.V. reported research support from the Department of Veterans Affairs, National Institutes of Health, and the Tahir and Jooma Family.S.V. reported honorarium: American College of Cardiology (Associate Editor for Innovations, acc.org). All other authors reported no conflicts of interest.",
year = "2024",
month = feb,
doi = "10.1016/j.jtcvs.2023.05.028",
language = "English",
volume = "167",
pages = "723--730.e4",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "2",
}